2 completed, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow ASP8062: new trials by email Literature Review of ASP8062 trials Research Report on ASP8062
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Laboratory Study of ASP8062 for Alcohol Use Disorder ASP8062, Placebo - Alcohol Use Disorder, Alcohol Drinking | Phase 2 | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 60 | 2021-12-13 | 2024-12-03 |
| A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder ASP8062, Placebo ASP8062, buprenorphine/naloxone - Opioid Use Disorder | Phase 2 | Withdrawn | Astellas Pharma Global Development, Inc. | 2021-11-08 | 2024-11-06 | |
| A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia ASP8062, Placebo - Fibromyalgia | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 183 | 2017-05-08 | 2025-11-03 |
Alcohol Drinking (1) · Alcoholism (1) · Fibromyalgia (1) · Opioid-Related Disorders (1)
Astellas Pharma Global Development, Inc. (2) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)
United States (2)